{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:24:41Z","timestamp":1792448681911,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE), underscoring an urgent need for non-invasive diagnostic biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to define the metabolomic signature of urinary extracellular vesicles (uEVs) in LN and to identify novel biomarkers for precision diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>uEVs were isolated from urine samples of 29 SLE patients with LN, 22 SLE patients without renal involvement, and 20 healthy controls (HCs) using a standardized precipitation-based protocol. uEVs were rigorously characterized in accordance with the Minimal Information for Studies of Extracellular Vesicles (MISEV) guidelines, including transmission electron microscopy, nanoparticle tracking analysis, and the assessment of canonical EV markers. Comprehensive untargeted metabolomic profiling of uEVs was subsequently performed using liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 284 differential metabolites were identified between LN patients and the SLE group, including 230 upregulated and 54 downregulated metabolites. Machine learning\u2013based feature prioritization using a random forest algorithm identified a panel of ten candidate metabolites. Notably, three metabolites\u2014Glucosylsphingosine (Lyso-Gb1), phosphatidylethanolamine N-methylated (PE-NMe), and PC(20:5\/TXB2)\u2014demonstrated excellent discriminatory performance for differentiating LN from non-renal SLE, with areas under the receiver operating characteristic curve (AUCs) of 0.912, 0.906, and 0.897, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We identified a distinct uEV metabolic signature in LN and developed a robust, non-invasive biomarker panel. This strategy holds significant promise for the early detection and personalized management of LN, offering a compelling alternative to invasive renal biopsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1741455","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:33:09Z","timestamp":1771309989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary extracellular vesicle metabolomic profiling reveals a distinct molecular signature for the non-invasive diagnosis of lupus nephritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Nan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anran","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, University of Science and Technology Bannu","place":["Bannu, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjing","family":"Rui","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Nanjing, China"]},{"name":"State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), Nanjing University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus","volume":"403","author":"Hoi","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu Rev Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09513-x","article-title":"Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus","volume":"647","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01267-0","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"21","author":"Patino-Martinez","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"B7","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-025-00653-y","article-title":"Lupus nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"De Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01277-y","article-title":"Addressing the challenge of global delays in diagnosis and treatment of systemic lupus erythematosus","volume":"21","author":"Pons-Estel","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","article-title":"Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01074-2","article-title":"Clinical relevance of extracellular vesicles in cancer - therapeutic and diagnostic potential","volume":"22","author":"Greening","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713560","article-title":"Identification of a non-invasive urinary exosomal biomarker for diabetic nephropathy using data-independent acquisition proteomics","volume":"24","author":"Ding","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"sfaf295","DOI":"10.1093\/ckj\/sfaf295","article-title":"Urinary extracellular vesicle RNAs as novel biomarkers for diagnosis and prognosis of lupus nephritis","volume":"18","author":"Zhang","year":"2025","journal-title":"Clin Kidney J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1038\/s41467-025-62229-4","article-title":"Single urinary extracellular vesicle proteomics identifies complement receptor CD35 as a biomarker for sepsis-associated acute kidney injury","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1077645","article-title":"Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-025-00023-5","article-title":"Machine learning-based identification of novel exosome-derived metabolic biomarkers for the diagnosis of systemic lupus erythematosus and differentiation of renal involvement","volume":"45","author":"Wang","year":"2025","journal-title":"Curr Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-025-01689-z","article-title":"Non-canonical small noncoding RNAs in the plasma extracellular vesicles as novel biomarkers in gastric cancer","volume":"18","author":"Yang","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1326836","article-title":"Circulating exosomal microRNAs as biomarkers of lupus nephritis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1677","article-title":"Serum exosomal tsRNA biomarkers: A novel strategy for identifying lupus nephritis","volume":"14","author":"Yang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12951-023-01908-0","article-title":"Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer","volume":"21","author":"Yang","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: A review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.105","article-title":"Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis","volume":"49","author":"Wada","year":"1996","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000132","article-title":"Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis","volume":"69","author":"Avihingsanon","year":"2006","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12093","article-title":"Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles","volume":"10","author":"Erdbrugger","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/metabo12020134","article-title":"Glycosphingolipid levels in urine extracellular vesicles enhance prediction of therapeutic response in lupus nephritis","volume":"12","author":"Troyer","year":"2022","journal-title":"Metabolites"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13023-023-02623-7","article-title":"Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review","volume":"18","author":"Giuffrida","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314938","article-title":"Glucosylsphingosine (Lyso-Gb(1)): an informative biomarker in the clinical monitoring of patients with Gaucher disease","volume":"23","author":"Gayed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2012.07.017","article-title":"Physiological roles of phosphatidylethanolamine N-methyltransferase","volume":"1831","author":"Vance","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195172","article-title":"Oxidized phosphatidylcholines are produced in renal ischemia reperfusion injury","volume":"13","author":"Solati","year":"2018","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.3390\/ijms22084194","article-title":"Extracellular vesicles tune the immune system in renal disease: A focus on systemic lupus erythematosus, antiphospholipid syndrome, thrombotic microangiopathy and ANCA-vasculitis","volume":"22","author":"Mazzariol","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1741455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:33:10Z","timestamp":1771309990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1741455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1741455"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1741455","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"article-number":"1741455"}}